Natco Pharma Share Price Target Tomorrow 2025 To 2030 – Stock Market Update, Today Chart

Natco Pharma Share Price Target

Natco Pharma Share Price Target 2025 To 2030 – Natco Pharma Limited is an Indian multinational pharmaceutical company which is based in Hyderabad, Telangana. Natco Pharma Share Price on NSE as of 21 January 2025 is 1,246.00 INR. The company was started in 1981 and has specialization in the formulation and manufacturing as well as marketing of formulations and APIs. Natco has a considerable market penetration in the generics segment especially in oncology, cardiology and CNS therapeutic segment.

The company has multiple manufacturing facilities within India and has an international presence, exporting its products to more than forty countries across the world. Natco also has the right approach towards quality and compliance; the company assures that its products are compliant with various markets across the world.

Natco Pharma Share Price Current Market Overview

  • Open: 1,259.00
  • High: 1,266.25
  • Low: 1,240.00
  • Current Share Price: 1,246.00
  • Market Capital: 22.41KCr
  • P/E: 11.48
  • Dividend Yield: 0.46%
  • 52 Week High: 1,639.00
  • 52 Week Low: 828.00

Natco Pharma Share Price Chart

Natco Pharma Share Price Chart

Share Price Target Tomorrow From 2025 To 2030

Here are the details regarding the share price target of Natco Pharma Limited for upcoming years. This data is based on expert analysis, market valuation, and industrial trends.

Share Target Price Years Share Target Value
2025 1645
2026 2010
2027 2445
2028 2925
2029 3362
2030 3802

Shareholding Pattern For Natco Pharma

  • Promoters: 49.62%
  • Foreign Institutions: 17.94%
  • Domestic Institutions: 5.57%
  • Mutual Funds: 26.87%

Shareholding Pattern For Natco Pharma

Natco Pharma Annual Income Statement

The given shows the comparison between the revenue and net income of Natco Pharma Limited.

Natco Pharma Share Price Recent Graph

For detailed information regarding the annual income statement, go through the given table.

Particulars Info 2024 Y/Y Change
Revenue 41.27B 52.37% (+)
Operating Expenses 17.18B 38.04% (+)
Net Income 13.88B 94.09% (+)
Net Profit Margin 33.64 27.38% (+)
Earning Per Share 77.34 97.40% (+)
EBITDA 18.80B 94.38% (+)
Effective Tax Rate 17.04% N/A

Challenges For Natco Pharma Share Price

Patent Litigations And Legal Risks

There is always a likelihood that current and future patent lawsuits may hamper the launch of generic products, thus hurting the revenue and potential investor returns.

Regulatory Challenges

The implementation of intensive regulatory requirements in most of the markets anywhere in the world, particularly in the United States and European countries, affects the approval and entry of its products into the market.

Pricing Pressure 

High levels of competitive forces in the market imply that the prices of these generics may down and hence the profit margin will be cut down.

Currency Fluctuations 

Since a part of its revenues is earned in foreign currencies, exchange rate volatility also creates an unfavorable situation.

Read Also:- Mamata Machinery Share Price Target Tomorrow 2025 To 2030- Today Chart, Market Overview

Leave a Comment

Your email address will not be published. Required fields are marked *